206 related articles for article (PubMed ID: 26525720)
61. Trends in Health-Related Quality of Life After a Diagnosis of Ductal Carcinoma In Situ.
Hart V; Sprague BL; Lakoski SG; Hampton JM; Newcomb PA; Gangnon RE; Trentham-Dietz A
J Clin Oncol; 2016 Apr; 34(12):1323-9. PubMed ID: 26884560
[TBL] [Abstract][Full Text] [Related]
62. Ductal carcinoma in situ (DCIS) of the breast: evolving perspectives.
Sakorafas GH; Tsiotou AG
Cancer Treat Rev; 2000 Apr; 26(2):103-25. PubMed ID: 10772968
[TBL] [Abstract][Full Text] [Related]
63. Postoperative tamoxifen for ductal carcinoma in situ.
Staley H; McCallum I; Bruce J
Cochrane Database Syst Rev; 2012 Oct; 10():CD007847. PubMed ID: 23076938
[TBL] [Abstract][Full Text] [Related]
64. Ductal carcinoma in situ: a disease entity that merits more recognition.
Dereere E; Papadimitriou K; Tjalma W; Altintas S
Minerva Chir; 2015 Aug; 70(4):231-9. PubMed ID: 25916193
[TBL] [Abstract][Full Text] [Related]
65. Breast cancer risk factor associations differ for pure versus invasive carcinoma with an in situ component in case-control and case-case analyses.
Ruszczyk M; Zirpoli G; Kumar S; Bandera EV; Bovbjerg DH; Jandorf L; Khoury T; Hwang H; Ciupak G; Pawlish K; Schedin P; Masso-Welch P; Ambrosone CB; Hong CC
Cancer Causes Control; 2016 Feb; 27(2):183-98. PubMed ID: 26621543
[TBL] [Abstract][Full Text] [Related]
66. Communication between patients and providers and informed decision making.
Elmore JG; Ganschow PS; Geller BM
J Natl Cancer Inst Monogr; 2010; 2010(41):204-9. PubMed ID: 20956831
[TBL] [Abstract][Full Text] [Related]
67. Knowledge, satisfaction with information, decisional conflict and psychological morbidity amongst women diagnosed with ductal carcinoma in situ (DCIS).
De Morgan S; Redman S; D'Este C; Rogers K
Patient Educ Couns; 2011 Jul; 84(1):62-8. PubMed ID: 20696544
[TBL] [Abstract][Full Text] [Related]
68. Severe fatigue after treatment of ductal carcinoma in situ: A comparison with age-matched breast cancer survivors and healthy controls.
Abrahams HJG; Smits L; Lugt M; Roos WK; Kamm Y; Heins MJ; Verhagen CAHHVM; Gielissen MFM; Knoop H
Breast; 2017 Feb; 31():76-81. PubMed ID: 27816835
[TBL] [Abstract][Full Text] [Related]
69. Ductal carcinoma in situ (DCIS). A highly treatable breast cancer.
Mayo Clin Womens Healthsource; 2009 Oct; 13(10):1-2. PubMed ID: 19727033
[No Abstract] [Full Text] [Related]
70. 'A mastectomy for something that wasn't even truly invasive cancer'. Women's understandings of having a mastectomy for screen-detected DCIS: a qualitative study.
Prinjha S; Evans J; Ziebland S; McPherson A
J Med Screen; 2011; 18(1):34-40. PubMed ID: 21536815
[TBL] [Abstract][Full Text] [Related]
71. Women's experiences of non-invasive breast cancer: literature review and study report.
Webb C; Koch T
J Adv Nurs; 1997 Mar; 25(3):514-25. PubMed ID: 9080278
[TBL] [Abstract][Full Text] [Related]
72. Long term clinical follow-up of atypical ductal hyperplasia and lobular carcinoma in situ in breast core needle biopsies.
Renshaw AA; Gould EW
Pathology; 2016 Jan; 48(1):25-9. PubMed ID: 27020205
[TBL] [Abstract][Full Text] [Related]
73. Ductal carcinoma in situ of the breast: diagnosis and management.
Friedrich M; Felberbaum R; Krämer S; Axt-Fliedner R; Diedrich K
Onkologie; 2003 Dec; 26(6):588-95. PubMed ID: 14709936
[TBL] [Abstract][Full Text] [Related]
74. Risk of subsequent invasive breast cancer after a diagnosis of ductal carcinoma in situ (DCIS).
Cheung S; Booth ME; Kearins O; Dodwell D
Breast; 2014 Dec; 23(6):807-11. PubMed ID: 25270228
[TBL] [Abstract][Full Text] [Related]
75. Is DCIS Overrated?
Feinberg J; Wetstone R; Greenstein D; Borgen P
Cancer Treat Res; 2018; 173():53-72. PubMed ID: 29349758
[TBL] [Abstract][Full Text] [Related]
76. 'Ductal carcinoma in situ of the breast' -- is it time to replace this term by 'ductal intraepithelial neoplasia of the breast'?
Tavassoli FA; Sakorafas GH
Onkologie; 2009 Apr; 32(4):218. PubMed ID: 19372721
[No Abstract] [Full Text] [Related]
77. Is there a low-grade precursor pathway in breast cancer?
King TA; Sakr RA; Muhsen S; Andrade VP; Giri D; Van Zee KJ; Morrow M
Ann Surg Oncol; 2012 Apr; 19(4):1115-21. PubMed ID: 21935747
[TBL] [Abstract][Full Text] [Related]
78. Current Approaches to Diagnosis and Treatment of Ductal Carcinoma In Situ and Future Directions.
Ryan R; Tawfik O; Jensen RA; Anant S
Prog Mol Biol Transl Sci; 2017; 151():33-80. PubMed ID: 29096897
[TBL] [Abstract][Full Text] [Related]
79. Ductal carcinoma in situ: trends in geographic, temporal, and demographic patterns of care and survival.
Joslyn SA
Breast J; 2006; 12(1):20-7. PubMed ID: 16409583
[TBL] [Abstract][Full Text] [Related]
80. Histological markers that predict clinical recurrence in ductal carcinoma in situ of the breast: an Australian population-based study.
Provenzano E; Hopper JL; Giles GG; Marr G; Venter DJ; Armes JE
Pathology; 2004 Jun; 36(3):221-9. PubMed ID: 15203725
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
